Lung repair by tetraspanin interacting protein IGSF3

Ended Project Grant Awarded Last action

Award ID
W81XWH2210255
Recipient
Awarding agency
Obligated
$5,138,136

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $2,569,068.00 Federal
  • $2,569,068.00 Non-federal
Place of performance
Denver, CO 80206, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The National Jewish Health in Denver, Colorado will receive $5.14 million through June 2026 under a Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve health care for service members and the public.

Through this funding, National Jewish Health will conduct research on lung repair using the tetraspanin interacting protein IGSF3. The goal is to investigate medical solutions for battlefield injuries and transform health care overall. The grant will support basic, applied, and advanced work over four years to better understand lung disease and identify potential new treatments. Findings have implications for service members suffering lung trauma as well as civilian health challenges.

Quick answers

Who received award W81XWH2210255?

W81XWH2210255 was awarded to National Jewish Health by Medical Command (Department of the Army) on July 1, 2022.

How much is award W81XWH2210255 worth?

$5,138,136 has been obligated on W81XWH2210255: $2,569,068 in federal funding and $2,569,068 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login